Results 171 to 180 of about 124,601 (306)

Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis

open access: yes, 2019
Rui Gao,1 Jin-Hua Liang,2 Tian-Shuo Man,2 Li Wang,2 Hua-Yuan Zhu,2 Wei Wu,2 Lei Fan,2 Jian-Yong Li,2 Tao Yang,1,* Wei Xu2,*1Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing ...
Gao R   +9 more
core  

Computed tomography findings of peritoneal tumour in the absence of primary lesions: preliminary study

open access: yesAustralian Veterinary Journal, EarlyView.
Primary peritoneal tumours are uncommon and include mesothelioma and carcinoma. Mesothelioma identification is challenging, as there are no established rapid diagnostic methods. In the absence of a simple means of diagnosis, evaluation often requires several invasive biopsies, highlighting the need to develop a definitive diagnostic method.
T Tanaka, M Tomihari, T Hasegawa
wiley   +1 more source

Diffuse Large B-Cell Lymphoma Arising in Postpneumonectomy Cavities: Report of Two Cases and Literature Review. [PDF]

open access: yesCase Rep Med
Capdevila P   +9 more
europepmc   +1 more source

Targeted Therapies and Immunotherapies for Diffuse Large B-Cell Lymphoma

open access: yes
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma (NHL) [...
Jahnavi Chaudhari, Nikesh N. Shah
core   +1 more source

Machine learning‐driven investigation on liquid–liquid phase separation‐related prognostic signature in diffuse large B‐cell lymphoma

open access: yesBritish Journal of Haematology, EarlyView.
Summary Diffuse large B‐cell lymphoma (DLBCL) is the most common aggressive non‐Hodgkin lymphoma and is characterized by substantial heterogeneity. This study aimed to develop a liquid–liquid phase separation (LLPS)‐related prognostic model to improve risk stratification.
Zhen‐Zhong Zhou   +11 more
wiley   +1 more source

Metabolic heterogeneity‐based radiomic model predicts treatment outcomes of primary mediastinal B‐cell lymphoma patients in the IELSG37 study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Early identification of patients at risk of failing first‐line therapy remains a key challenge in primary mediastinal B‐cell lymphoma (PMBCL). This study assessed whether positron emission tomography (PET) radiomics could predict treatment outcomes in PMBCL.
L. Ceriani   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy